logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Necker Hospital

+33144494000
contact.dossiermedical@aphp.fr
Source: Site record.
https://www.hopital-necker.aphp.fr

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Necker-Enfants Malades Hospital offers the full range of pediatric medical and surgical specialties, a pediatric emergency department, and a Level III maternity unit. It also provides highly specialized adult services, including nephrology, kidney transplantation, hematology, and infectious diseases. It is also home to SAMU 75.With nearly 60 rare disease centers and extensive expertise in severe and complex conditions, its teams have developed a high-level approach to medical care supported by strong collaboration between clinical units, research units, and advanced medical and technical facilities. Its 5,000 professionals care for more than 500,000 patients each year, nearly 17% of whom come from other regions of France or from abroad.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Children's hospital

Business Subcategory

Source: Human-provided. Children's hospital
Source: Human-provided. General hospital
Source: Trial-derived.
169Total Trials
Source: Trial-derived.
51Recruiting Trials
Source: Trial-derived.
81Active Trials
Source: Trial-derived.
69Completed Trials
Source: Trial-derived.
220Unique Conditions
Source: Trial-derived.
182Unique Sponsors

Conditions

Source: Trial-derived. Cystic Fibrosis (5)Source: Trial-derived. Kidney Transplantation (5)Source: Trial-derived. Sickle Cell Disease (4)Source: Trial-derived. Alport Syndrome (3)Source: Trial-derived. Kidney Transplant Rejection (3)Source: Trial-derived. Multiple Myeloma (3)Source: Trial-derived. Allogeneic Hematopoietic Cell Transplant (2)Source: Trial-derived. Autosomal Dominant Polycystic Kidney (2)

Sponsors

Source: Trial-derived. Assistance Publique - Hôpitaux de Paris (27)Source: Trial-derived. URC-CIC Paris Descartes Necker Cochin (19)Source: Trial-derived. Hôpital Necker-Enfants Malades (9)Source: Trial-derived. Hospices Civils de Lyon (9)Source: Trial-derived. Nantes University Hospital (9)Source: Trial-derived. Institut National de la Santé Et de la Recherche Médicale, France (7)Source: Trial-derived. University Hospital, Tours (6)Source: Trial-derived. ANRS, Emerging Infectious Diseases (5)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Caregiver / family support
Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. X-Ray
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. DEXA Scan
Source: AI-inferred. Echocardiography
Source: AI-inferred. Six-minute walk test
Source: AI-inferred. Spirometry
Source: AI-inferred. MRI

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. Biobanking

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Blood transfusion service
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Dialysis
Source: AI-inferred. Surgery / operating room

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Amenities

Amenities Available

Source: Google. Nursing room

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Complement component and CH50 functional testing
Source: AI-inferred. Computerized cognitive assessment battery
Source: AI-inferred. Cytokine and soluble cytokine receptor testing
Source: AI-inferred. Deceased donor kidney transplantation
Source: AI-inferred. Dermatology specialist assessment
Source: AI-inferred. Dietitian-led dietary intake monitoring
Source: AI-inferred. Donor-recipient crossmatch testing
Source: AI-inferred. Electronic diary (ePRO/ObsRO) system